Skip to main content
Premium Trial:

Request an Annual Quote

NIH Launches Microbiome Cloud Project

Premium

The National Institutes of Health has launched the first phase of the Microbiome Cloud Project, or MCP, a collaborative project with Amazon Web Services that aims to improve access to and analysis of data from the Human Microbiome Project.

In this phase, five terabytes of genetic information from human microbes have been made available on the cloud. This makes it easy for researchers to access and analyze the data online without having to worry about time-consuming downloads or compute infrastructure. Mining HMP data could help researchers understand the role of the microbiota in health and disease as well as uncover new targets for drugs and vaccines.

The MCP development team, which is led by researchers at the University Of Maryland School Of Medicine, has begun working on the next phase of the MCP, which will add more datasets, analysis tools, and supporting documentation. The researchers are funded by the National Institute of Allergy and Infectious Diseases and the National Human Genome Research Institute.

Filed under

The Scan

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.

Study Reveals Potential Sex-Specific Role for Noncoding RNA in Depression

A long, noncoding RNA called FEDORA appears to be a sex-specific regulator of major depressive disorder, affecting more women, researchers report in Science Advances.

New mRNA Vaccines Offer Hope for Fighting Malaria

A George Washington University-led team has developed mRNA vaccines for malaria that appear to provide protection in mice, as they report in NPJ Vaccines.

Unique Germline Variants Found Among Black Prostate Cancer Patients

Through an exome sequencing study appearing in JCO Precision Oncology, researchers have found unique pathogenic or likely pathogenic variants within a cohort of Black prostate cancer patients.